Pet Biotics Market
Pet Biotics Market By Type (Probiotics, Prebiotics, and Postbiotics), Application (Dry, Wet, Supplements, and Snacks & Treats), Pet (Dogs, Cats, and Other Pets), Form, Function, Manufacturing Technology, and Region - Global Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The pet biotics market is projected to reach USD 1,232.5 million by 2030 from USD 878.1 million in 2025, at a CAGR of 7.0% from 2025 to 2030. The growth of the pet biotics market is driven by the rising pet humanization and preventive health focus, and growing veterinary recommendations and clinical backing.
KEY TAKEAWAYS
-
BY REGIONThe North American pet biotics market accounted for a 39.7% share in 2025.
-
BY TYPEBy type, the postbiotic segment is expected to register a higher CAGR of 8.1%.
-
BY APPLICATIONBy application, the supplements segment is projected to grow at the highest rate from 2025 to 2030.
-
BY PETBy pet, the dog segment is expected to dominate the market.
-
BY FORMBy form, the dry segment is expected to hold a significant market share.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSADM, Alltech, and Kerry Group PLC were identified as some of the star players in the pet biotics market (global), given their strong market share and product footprint.
-
COMPETITIVE LANDSCAPE - STARTUPSBiotenova Sdn. Bhd., Pellucid Lifesciences Pvt. Ltd, and Verb Biotics, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The pet biotics market is expected to grow at a rapid rate due to increasing awareness of pet health and functional nutrition, advancements in formulation and delivery technology, and rising investments by major market players.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The impact on consumers' business emerges from customer trends or disruptions. Hotbets are new, emerging types and strains of biosolutions, targeting end users who are clients of pet biotic ingredient manufacturers. Shifts, which are changing trends or disruptions, will impact the revenues of end users, thus affecting the revenues of hotspots and further the revenues of pet biotic manufacturers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising pet humanization and preventive health focus

-
Growing veterinary recommendation and clinical backing
Level
-
Heat and moisture sensitivity of microbial strains
-
Shelf-life viability concerns
Level
-
Increase in pet expenditure, with a substantial increase in pet food expenditure
-
Rising demand for gut-health-focused and functional pet foods
Level
-
Supply chain complexity for live microbes
-
Competition from alternative digestive health solutions
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising pet humanization and preventive health focus
Pet owners are increasingly viewing dogs and cats as family members, leading to a significant shift in spending behavior and nutritional priorities. This “pet parent” mindset has elevated expectations for care quality, wellness, and emotional bonding — a trend similar to those observed in human health and lifestyle.
Restraint: Heat and moisture sensitivity of microbial strains
One of the major restraints in the pet biotics market is the heat and moisture sensitivity of microbial strains used as functional ingredients. The stability of probiotic microorganisms during pet food manufacturing and storage remains a major technical restraint in the market.
Opportunity: Increase in pet expenditure, with a substantial increase in pet food expenditure
The steady rise in global pet ownership has been accompanied by a significant surge in overall pet expenditure, particularly in food and nutrition categories. Pet owners increasingly view their pets as family members, prioritizing premium nutrition and health-related products over cost-based decisions.
Challenge: Supply chain complexity for live microbes
The supply chain for live microbial ingredients in the pet biotics market presents significant operational and logistical challenges. Unlike conventional feed additives, probiotic strains are biologically active and highly sensitive to environmental conditions, requiring precise handling throughout their production and distribution.
pet-biotics-market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
A&B Ingredients developed its proprietary probiotic strain PA5051 ( Pediococcus acidilactici PA5051 ) for use in both human/animal nutrition and pet food/pet supplement applications. | For the pet supplement/food manufacturer: access to a differentiating probiotic ingredient with strong stability and performance claims (which supports premium positioning). |
|
|
Chr. Hansen (part of Novonesis Group) expanded its microbial expertise into the pet health and nutrition market with the introduction of a new portfolio of stable live probiotics for use in pet foods and supplements. | This science-based probiotic portfolio targets to meet the distinct needs of pets throughout their lifespan. |
|
|
Alltech introduced MICROBUILD, a new prebiotic fiber designed to support gut health in pets by promoting beneficial microbiota and improving digestive function. | This innovation reflects the growing consumer demand for functional pet nutrition, positioning Alltech to strengthen its presence in the companion animal health market with scientifically backed solutions. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The pet biotics ecosystem is categorized into manufacturers, regulatory bodies, and end-use companies. The pet biotics market is a dynamic and rapidly expanding ecosystem characterized by diverse stakeholders and innovative products. Established companies and agile startups are central to this market, and they develop pet biotic products.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Pet Biotics Market, By Type
The probiotic segment is expected to dominate the market due to strong consumer demand for functional nutrition that supports digestive health, immunity, and overall well-being in pets.
Pet Biotics Market, By Pet
The dog segment holds a significant market share due to the increasing humanization of pets, where pet owners are more inclined to treat their dogs as family members and invest in their overall health and wellness.
Pet Biotics Market, By Form
Dry biotics, including powders, granules, and extrudable dry ingredients, are more widely adopted in commercial pet food and supplements due to their longer shelf life, higher stability, easier storage and transport, and better compatibility with processing technologies such as extrusion and baking.
Pet Biotics Market, By Application
Dry pet food application holds a significant share due to its wide adoption, ease of storage, long shelf life, and compatibility with biotic ingredients.
REGION
Asia Pacific to be fastest-growing region in global pet biotics market during the forecast period
The Asia Pacific pet biotics market is expected to register the highest CAGR during the forecast period, driven by the demand for functional pet foods that support gut health, immunity, and overall wellness of pets.

pet-biotics-market: COMPANY EVALUATION MATRIX
In the pet biotics market matrix, ADM and Alltech (Star) lead with a strong market share and extensive product footprint for pets, driven by their strong geographical presence, significant formulation and distribution capabilities, and strong ties with pet food manufacturers. Orffa (Emerging Leader) is gaining visibility with its specialized pet biotic offerings for pet applications, strengthening its position through strong product offerings.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- ADM (US)
- Alltech (US)
- dsm-firmenich (Netherlands)
- International Flavors & Fragrances Inc. (US)
- Kerry Group plc (Ireland)
- Cargill, Incorporated (US)
- Probi (Sweden)
- Kemin Industries, Inc. (US)
- BENEO GmbH (Germany)
- Ingredion (US)
- Lallemand Inc. (Canada)
- Sacco System (Italy)
- Phileo by Lesaffre (France)
- Sanzyme Biologics (India)
- Orffa (Netherlands)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 825.2 Million |
| Market Forecast in 2030 (Value) | USD 1,232.5 Million |
| Growth Rate | CAGR of 7.0% from 2025 to 2030 |
| Years Considered | 2021–2030 |
| Base Year | 2024 |
| Forecast Period | 2025–2030 |
| Units Considered | Value (USD Million), Volume (Tons) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, South America, and Rest of the World |
| Leading Segments | By type, the postbiotic segment is expected to register a higher CAGR of 8.1%. |
| Leading Region | The North American pet biotics market accounted for a 39.7% share in 2025. |
| Driver | Rising pet humanization and preventive health focus |
| Constraints | Heat and moisture sensitivity of microbial strains |
WHAT IS IN IT FOR YOU: pet-biotics-market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Europe-based Pet Food Ingredient Manufacturers |
|
|
| Supplement Segment Assessment |
|
|
RECENT DEVELOPMENTS
- June 2025 : ADM opened a 1,600 m², state-of-the-art R&D center at Lausanne’s biopôle campus in Switzerland to conduct pre-clinical microbiome research for pets, livestock, and aquaculture—leveraging biotics and fermentation-derived ingredients to improve gut health, immunity, digestion, and longevity. This launch reflects the booming USD 5.2 billion global animal feed biotics market (as of 2024) and growing consumer and producer demand for science-backed nutritional solutions.
- August 2024 : Kerry announced a two-year strategic partnership with APC Microbiome Ireland at University College Cork to collaboratively research and develop novel biotic and postbiotic ingredients targeting the gut–brain axis, with the aim of improving cognitive health and mood, and a rapid market rollout following project completion.
- July 2024 : Cargill signed an exclusive distribution agreement with Brenntag Specialties Nutrition for its postbiotic ingredient EpiCor, made from fermented baker’s yeast (Saccharomyces cerevisiae). This deal encompasses a broad range of European regions, including the UK, Ireland, France, Germany, the Nordics, the Baltics, and others. EpiCor is known for supporting immune and gut health, and this partnership aims to meet growing demand for functional health ingredients across Europe.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
-
5.1 PORTER’S FIVE FORCES ANALYSISINTENSITY OF COMPETITIVE RIVALRYTHREAT OF NEW ENTRANTSTHREAT OF SUBSTITUTESBARGAINING POWER OF SUPPLIERSBARGAINING POWER OF BUYERS
- 5.2 MACROECONOMICS INDICATORS
-
5.3 VALUE CHAIN ANALYSISRESEARCH & PRODUCT DEVELOPMENTRAW MATERIAL SOURCING AND STRAIN IDENTIFICATIONPROCESSING AND MANUFACTURING OPERATIONSDISTRIBUTION & LOGISTICSEND-USER SEGMENTS AND CONSUMPTION PATTERNSVALUE ADDED ACROSS THE VALUE CHAIN
-
5.4 ECOSYSTEM ANALYSISDEMAND SIDESUPPLY SIDE
-
5.5 PRICING ANALYSISAVERAGE SELLING PRICE TREND OF PRODUCT TYPE, BY KEY PLAYERS (2024)AVERAGE SELLING PRICE TREND, BY REGION (2021-2024)
-
5.6 TRADE ANALYSISEXPORT SCENARIO (HS CODE 3002) – MAJOR EXPORTING COUNTRIES & REGIONSIMPORT SCENARIO (HS CODE 3002) – MAJOR IMPORTING COUNTRIES & REGIONS
- 5.7 KEY CONFERENCES & EVENTS IN 2025-2026
- 5.8 TRENDS/DISRUPTIONS IMPACTING THE CUSTOMER’S BUSINESS
- 5.9 INVESTMENT AND FUNDING SCENARIO
- 5.10 CASE STUDY ANALYSIS
-
5.11 IMPACT OF 2025 US TARIFF – PET BIOTICS MARKETINTRODUCTIONKEY TARIFF RATESPRICE IMPACT ANALYSISIMPACT ON COUNTRY/REGION*- US- Europe- Asia PacificIMPACT ON END-USE INDUSTRIES
-
6.1 KEY TECHNOLOGIESFERMENTATIONFILTRATIONFREEZE-DRYING (LYOPHILIZATION)MICROENCAPSULATION & NANOENCAPSULATION
-
6.2 COMPLEMENTARY TECHNOLOGIESIOT-BASED FERMENTATION MONITORINGENZYMATIC HYDROLYSIS
-
6.3 ADJACENT TECHNOLOGIESGENOME-SCALE METABOLIC MODELINGBIOINFORMATICSDIGITAL FERMENTATION CONTROL
-
6.4 PATENT ANALYSISLIST OF MAJOR PATENTS PERTAINING TO THE MARKET
- 6.5 FUTURE & EMERGING PRODUCTS OF PET BIOTICS
-
6.6 IMPACT OF GEN AI ON PET FOOD INDUSTRYINTRODUCTIONUSE OF GEN AI IN PET FOOD INDUSTRYCASE STUDY ANALYSISIMPACT ON PET BIOTICS MARKETADJACENT ECOSYSTEM WORKING ON GEN AI
- 6.7 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
-
7.1 REGIONAL REGULATIONSREGULATORY BODIES AND FRAMEWORKSCERTIFICATION AND ACCREDITATION BODIESLABELLING REQUIREMENTS AND CLAIMSANTICIPATED REGULATORY CHANGES OVER THE NEXT 5-10 YEARS
-
7.2 SUSTAINABILITY INITIATIVESSUSTAINABLE SOURCINGCARBON FOOTPRINT REDUCTION INITIATIVESCIRCULAR ECONOMY APPROACHESCERTIFICATION, TRACEABILITY & TRANSPARENCY
- 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
- 7.4 BIODEGRADABLE PACKAGING, CERTIFICATIONS, LABELING, ECO-STANDARDS
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
- 9.1 INTRODUCTION
-
9.2 PROBIOTICSBACTERIA- Lactobacillus- Bifidobacterium- Bacillus- Enterococcus- Streptococcus ThermophilusYEAST & FUNGI- Saccharomyces Boulardii- Saccharomyces Cerevisiae- Other Yeast & Fungi
-
9.3 PREBIOTICSOLIGOSACCHARIDES- Fructooligosaccharides (FOS)- Galactooligosaccharides (GOS)- Mannanoligosaccharides (MOS)- Other OligosaccharidesINULINPOLYDEXTROSEOTHER PREBIOTIC INGREDIENT TYPES (BETA-GLUCANS, RESISTANT STARCHES, PECTIN)
-
9.4 POSTBIOTICSBACTERIA- Lactobacillus- Bifidobacterium- Other BacteriaYEAST- Saccharomyces Boulardii- Saccharomyces Cerevisiae
- 10.1 INTRODUCTION
- 10.2 DRY FOOD
- 10.3 WET FOOD
- 10.4 SUPPLEMENTS
- 10.5 SNACKS & TREATS
- 11.1 INTRODUCTION
- 11.2 DOGS
- 11.3 CATS
- 11.4 OTHER PETS (BIRDS, EQUINE, AND OTHER SMALL MAMMALS)
- 12.1 INTRODUCTION
- 12.2 DRY
- 12.3 LIQUID
- 13.1 INTRODUCTION
- 13.2 DIGESTIVE/GUT HEALTH
- 13.3 IMMUNE MODULATION
- 13.4 METABOLIC & WEIGHT MANAGEMENT
- 13.5 ORAL & DENTAL HEALTH
- 13.6 OTHER FUNCTIONS
- 14.1 INTRODUCTION
- 14.2 FERMENTATION
- 14.3 CENTRIFUGATION & FILTRATION
- 14.4 DRYING & STABILIZATION
- 14.5 ENCAPSULATION & PROTECTION
- 14.6 INACTIVATION & CELL DISRUPTION
- 14.7 FORMULATION & BLENDING
- 14.8 QUALITY CONTROL & STORAGE
-
15.1 NORTH AMERICAUSCANADAMEXICO
-
15.2 EUROPEGERMANYUKFRANCESPAINITALYREST OF EUROPE
-
15.3 ASIA PACIFICCHINAJAPANINDIAAUSTRALIA & NEW ZEALANDREST OF ASIA PACIFIC
-
15.4 SOUTH AMERICABRAZILARGENTINAREST OF SOUTH AMERICA
-
15.5 REST OF THE WORLDMIDDLE EASTAFRICA
- 16.1 OVERVIEW
- 16.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2022 - 2025
- 16.3 REVENUE ANALYSIS, 2022 – 2024
- 16.4 MARKET SHARE ANALYSIS, 2024
- 16.5 BRAND/PRODUCT COMPARISON
- 16.6 COMPANY VALUATION AND FINANCIAL METRICS
-
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024STARSEMERGING LEADERSPERVASIVE PLAYERSPARTICIPANTSCOMPANY FOOTPRINT: KEY PLAYERS, 2024- Company Footprint- Region Footprint- Type Footprint- Pet Footprint
-
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024PROGRESSIVE COMPANIESRESPONSIVE COMPANIESDYNAMIC COMPANIESSTARTING BLOCKSCOMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024- Detailed list of key start-up/SMEs- Competitive benchmarking of key start-ups/SMEs
-
16.9 COMPETITIVE SCENARIONEW PRODUCT LAUNCHESDEALSEXPANSIONSOTHERS
-
17.1 KEY PLAYERSDSM-FIRMENICHINTERNATIONAL FLAVORS & FRAGRANCES INC.KERRY GROUP PLCADMCARGILL, INCORPORATED.KEMIN INDUSTRIES, INC.BENEO GMBHINGREDIONALLTECHLALLEMAND INC.SACCO SYSTEMPHILEO BY LESAFFRESANZYME BIOLOGICSORFFABIO-CAT
-
17.2 STARTUPS/SMESSPECIALTY ENZYMES & PROBIOTICSCREATIVE ENZYMESSYNBIO TECH INC.CANBIOCIN INC.VERB BIOTICSBIOTENOVA SDN. BHD.BIOPROX HEALTHCARESTRATUM NUTRITIONWIPWIP
-
18.1 RESEARCH DATASECONDARY DATA- Key data from secondary sourcesPRIMARY DATA- Key data from primary sources- Key Industry Insights- Breakdown of Primaries
-
18.2 MARKET SIZE ESTIMATIONBOTTOM-UP APPROACH- Approach For Capturing Market Share By Bottom-Up AnalysisTOP-DOWN APPROACH- Approach For Capturing Market Share By Top-Up Analysis
- 18.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 18.4 RESEARCH ASSUMPTIONS
- 18.5 RISK ASSESSMENT
- 18.6 LIMITATIONS
- 18.7 ADJACENT & RELATED MARKETS
- 19.1 DISCUSSION GUIDE
- 19.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- 19.3 AVAILABLE CUSTOMIZATIONS
- 19.4 RELATED REPORTS
- 19.5 AUTHOR DETAILS
Methodology
This study employed two primary approaches to estimate the current size of the pet biotics market. Exhaustive secondary research was conducted to gather information on the type, application, pet, form, function, and manufacturing technology segments of the market (qualitative). The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.
Secondary Research
This research study utilized extensive secondary sources, including directories and databases such as Bloomberg Businessweek and Factiva, to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, pet food journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on the industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.
Primary Research
Extensive primary research was conducted after obtaining information regarding the pet biotics market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief Experience Officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, as well as key executives from distributors and key opinion leaders.
Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to type, application, pet, form, functions, and manufacturing technology (qualitative), as well as region. Stakeholders from the demand side, including distributors, importers, exporters, and end-use sectors such as pet food and pet supplement manufacturers, were interviewed to gain insight into the buyers’ perspective on suppliers, products, and the outlook for their businesses, which will impact the overall market.
The three tiers of the companies are defined based on their total revenues in 2023 or 2024, based on the availability of financial data: Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue < USD 100 million.
RoW includes Africa and the Middle East.
|
COMPANY NAME |
DESIGNATION |
|
Cargill, Incorporated (US) |
Product Development Manager |
|
Bharat International Pet Foods Pvt. Ltd. (Manager) |
Sales Manager |
|
Purina Animal Nutrition LLC (US) |
Marketing Head |
|
BIOPROX (France) |
Marketing Head |
|
Alltech (US) |
Senior Sales Manager |
|
Kemin Industries, Inc. (US) |
Business Development Manager |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate and validate the total size of the pet biotics market. These approaches were also used extensively to determine the size of various market segments. The research methodology used to estimate the market size includes the following details:
- The key players in the industry and the overall markets were identified through extensive secondary research.
- All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
- All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
- The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.
Pet Biotics Market : Top-Down and Bottom-Up Approach

Data Triangulation
After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall pet biotics market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.
Market Definition
Pet biotics refer to a group of functional ingredients, including probiotics, prebiotics, and postbiotics, that are incorporated into pet foods, treats, toppers, and nutritional supplements to support gut health, digestion, immunity, nutrient absorption, and overall well-being. Probiotics are live beneficial microorganisms, prebiotics are non-digestible fibers that selectively nourish these beneficial microbes, and postbiotics are bioactive compounds produced through microbial fermentation. Together, these ingredients help maintain a balanced gut microbiome and enhance the health and performance of pets.
Key Stakeholders
- Probiotic strain manufacturers
- Prebiotics & postbiotics ingredient manufacturers
- Pet food and supplement product manufacturers
- Key companies engaged in pet food processing
- Intermediate stakeholders, including distributors, retailers, associations, regulatory bodies, and others
- Government organizations, institutes, and research organizations
-
Associations and industry bodies:
- Pet Food Institute (PFI)
- International Probiotics Association (IPA)
- International Scientific Association for Probiotics and Prebiotics (ISAPP)
- European Food Safety Authority (EFSA)
- American Pet Products Association
- Global Alliance of Pet Food Associations
- The European Pet Organization
- Association of American Feed Control Officials (AAFCO)
- American Veterinary Medical Association (AVMA)
Report Objectives
- To determine and project the size of the pet biotics market based on type, application, pet, form, function, manufacturing technology (qualitative), and region, over five years, ranging from 2025 to 2030
- To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
- To provide detailed information about the key factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the total market
- To identify and profile the key players in the market
- To understand the competitive landscape and identify the major growth strategies adopted by players across the key regions
Customization Options
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which provides a detailed comparison of each company's product portfolio.
Geographic Analysis
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
- Further breakdown of the Rest of European pet biotics market into key countries
- Further breakdown of the Rest of Asia Pacific pet biotics market into key countries
- Further breakdown of the Rest of South American pet biotics market into key countries
Company Information
- Detailed analyses and profiling of additional market players (up to five)
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Pet Biotics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Pet Biotics Market